Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, multicenter, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of KRP-116D in Japanese patients with interstitial cystisis

Next Previous
X
Search
Trial Profile

A Phase III, multicenter, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of KRP-116D in Japanese patients with interstitial cystisis

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dimethyl sulfoxide (Primary)
  • Indications Interstitial cystitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Kyorin Pharmaceutical

    • Most Recent Events

    • 01 Apr 2022 Results of post hoc analysis from Japanese phase III trial assessing efficacy of intravesical KRP-116D, 50% dimethyl sulfoxide solution, in interstitial cystitis/bladder pain syndrome patients with Hunner lesions (Hunner-type interstitial cystitis) published in the International Journal of Urology
    • 01 May 2021 Primary endpoint has been met. (Efficacy(OLeary and Sants IC symptom index))
    • 01 May 2021 Results evaluating the efficacy and safety of intravesical instillation of KRP-116D (50% DMSO solution) in IC/BPS patients with the bladder-centric phenotype published in the International Journal of Urology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top